our organization

Sites map

RECLIP is created on the basis of the clinical strength of the main pediatric hospitals, which are the backbone of the network, developing a relevant activity in pediatric clinical research.
Consolidated site
Thematic site
Emergent site
Comunidad de Madrid
País Vasco
Comunidad Valenciana
reclip’s network

RECLIP aims to address all the gaps regarding the development of pediatric clinical trials in Spain through a strong, exceptional and super-specialized network of pre-qualified clinical sites. It covers the specific needs of pediatric clinical trials in Spain in a professionalized, multidisciplinary, and organized manner, gathering the most important pediatric clinical research units across the country, corresponding to the most important hospitals of Spain, combined with primary care centers and thematic research networks that develop relevant activity in pediatric clinical research.

scientific network

Collaborations & Networking

National Networking

In Spain, specific efforts related to pediatric research are limited, and there is no specific official network or platform for pediatric clinical trials designed to address  and change this situation, which is why RECLIP took shape and was launched as an initiative promoted by the clinical representatives of the main pediatric hospitals in Spain and under the coordination and leadership of Prof. Dr. Federico Martinón Torres, Head of the Pediatrics Service of the Hospital Clínico Universitario de Santiago of Compostela.

The official establishment of the network was attended by members of the different institutions founders of the network, representatives of associations of the pharmaceutical industry (FarmaIndustria) and of the Spanish Agency of Medicines and Health Products (AEMPS) and the Carlos III Health Institute (ISCIII), as well as coordinators of existing clinical research networks such as the Maternal and Child Health Network - SAMID, the European Reference Network for Transplants in Children – TRANSCHILD and the Spanish Clinical Research Network – SCReN.
Other entities that have established collaborations with RECLIP are the Medical Association of the Pharmaceutical Industry (AMIFE) and the Spanish Association of Pediatrics (AEP).

woman scientist conducting an experiment

Institutional Endorsements and Collaborative Entities

  • Agencia Española Del Medicamento Y Productos Sanitarios

    Medicines And Healthcare Products Agency
  • Asociación Española De Pediatría

    Spanish Association Of Paediatrics
  • Farmaindustria

    National Trade Association Of The Spanish Based Pharmaceutical Industry
  • Asociación De Medicina De La Industria Farmacéutica (Amife)

    Medical Association Of The Pharmaceutical Industry
  • Red De Investigación Clínica Pediátrica De La Agencia Europea Del Medicamento

    European Network Of Paediatric Research At The European Medicines Agency

Thematic Networks

The thematic networks participating in RECLIP have a relevant role in our organization as a network, contributing as scientific societies, with their experience and sound knowledge in their corresponding research areas.

Through these thematic networks, RECLIP can contribute with expert knowledge when providing information of high added value aimed at both clinical trial sponsors and researchers at RECLIP sites.


The Spanish Society of Inborn Errors of Metabolism, SEEIM, was recognized by the AEP (Spanish Association of Pediatrics) in 2005. The SEEIM, through the knowledge and experience of its members, carries out numerous activities and conferences that serve as a reference for metabolic diseases in the pediatric population, in addition to developing activities that promote research in the field of these diseases. Read more Read less


The Spanish Society of Pediatric Rheumatology (SERPE) is a scientific society that brings together health professionals with an interest in Pediatric Rheumatology.
SERPE's mission is to promote the health of children and adolescents affected by rheumatic diseases based on comprehensive care for these diseases and the well-being of their families and to promote the development of research, knowledge and skills in the specialty, through holding scientific meetings, training activities, working groups and family associations related to rheumatic diseases in childhood.
Read more Read less


The SAMID network is now the new RICORS-SAMID network and has been funded in the 2021 call for Cooperative Research Networks Oriented to Health Results under the title “Primary Care Interventions to prevent maternal and child chronic diseases of perinatal and developmental origin” (RD21/0012). This RICORS maternal and child consortium, made up of 20 research groups and 27 associated clinical groups, aims to provide a comprehensive and synergistic plan across hospitals and primary care centers, and is aimed at improving the health of women, mothers and children, avoiding the consequences of perinatal and developmental complications. Read more Read less


The Spanish Society of Pediatric Hematology and Oncology is a non-profit medical-scientific association. It brings together children's oncologists and hematologists, pediatric surgeons, radiation therapists and other specialists committed to the study and treatment of childhood cancer.
The SEHOP encourages and promotes oncological research, as a fundamental pillar for achieving advances in cancer treatment.
Read more Read less


The European Child and Adolescent Clinical Psychopharmacology Network (ECAPN) is a well-established network of child and adolescent psychiatry clinical centers (currently 12), based in several EU countries, all of them experts in pediatric psychopharmacology.
ECAPN is an initiative of the ECNP Child and Adolescent Neuropsychopharmacology Network. Its objectives include identifying unmet needs in child and adolescent psychopharmacology, conducting scientific studies and collaborative clinical trials, and developing strategies to improve the prescribing of next-generation medications to children and adolescents with psychiatric disorders in clinical practice.
Read more Read less


Translational Research Network in Pediatric Infectious Diseases (RITIP), is an independent network which includes previously established pediatric infectious disease networks in Spain and the most important research groups.
The thematic of the network encompasses "all" those aspects of pediatric infectious diseases. This perspective includes epidemiology, pathophysiology, diagnosis, treatment, and prevention, with the purpose of modifying clinical practice in pediatric infectious diseases, avoiding infections through prevention and improving their prognosis through better diagnosis and treatment.
Read more Read less

International Networking

Under partnerships and through several collaborations RECLIP reaffirms and strengthens its presence with the main European stakeholders. As national hub, RECLIP has partnerships and collaborations with supra-national networks, mainly conect4children (collaborative network for European clinical trials for children - c4c), as well as disease-focused or other specialty networks.


conect4children (collaborative network for European clinical trials for children, c4c) is a large collaborative pediatric network that will facilitate the development of new drugs and other therapies for the entire pediatric population in Europe. RECLIP is the participant national hub in this collaborative network.

c4c aims to enhance the competitiveness of Europe as a critical region for developing medicines for children by using existing expertise, patient access and developing common processes to be applied to disease natural history studies, registries, studies of new therapies and comparisons of existing therapies.

The consortium is a currently a novel collaboration between academic and private sectors that includes 33 academic and 10 industry partners from 20 European countries, more than 50 third parties and around 500 affiliated partners.

The project is coordinated and led by: Fondazione PENTA – for the treatment and care of children with HIV – ONLUS, The University of Liverpool, Janssen Pharmaceutical NV and Bayer AG.

Sign up to c4c’s newsletter


RECLIP is classified as a member category 1 of EnprEMA.

The European Network of Pediatric Research at the European Medicines Agency, Enpr-EMA, is a network constituted by research networks, investigators and centres/sites with recognised expertise in performing clinical studies in children.

According to the evaluation received, RECLIP meets the required criteria established by EnprEMA to be awarded with the máximum category, bringing RECLIP at the top of the pediatric clinical research together with other outstanding networks across Europe. RECLIP has been recently (March 2022) succesfully re-evaluated as EnprEMA Category 1 member.

Through this joint effort we work to ensure that safe and effective clinical trials are designed and conducted for the pediatric population.

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Cookie Policy for more information.